At LOR Diagnostics, we are committed to helping support earlier awareness of cognitive health through advanced blood-based Alzheimer’s biomarker testing. Our testing options are designed to provide additional insight into potential Alzheimer’s-related changes using innovative laboratory technology and a simple blood sample.
Our advanced cognitive health testing is designed to provide additional insight into Alzheimer’s-associated biomarkers and genetic risk factors that may be associated with cognitive health changes over time.
This testing may be beneficial for individuals who:
APOE Insight evaluates specific genetic markers associated with Alzheimer’s disease risk, including APOE variants such as APOE2, APOE3, and APOE4. Certain APOE variants may be associated with an increased likelihood of developing Alzheimer’s disease later in life.
Amyloid Balance evaluates blood-based Alzheimer’s biomarkers, including pTau217 and Beta-Amyloid 1-42 ratio markers associated with amyloid pathology and cognitive health changes.
If you are interested in having this testing performed, please click the “Join the Waitlist” button and a member of our team will reach out to you with additional information regarding testing options, availability, and next steps.
All testing is performed by LOR Diagnostics, a CLIA- and CAP-accredited laboratory committed to quality, accuracy, and patient-focused care.
Copyright © 2025 LOR Diagnostics